Cutler Group LP Y M Abs Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$5.68 - $10.34 $6,816 - $12,408	1,200 Added 400.0%	1,500 $1,000
Q1 2023 May 01, 2023	BUY	$2.83 - $5.11 $849 - $1,533	300 New	300 $0
Q3 2022 Oct 25, 2022	SELL	$13.96 - $19.67 $15,356 - $21,637	-1,100 Reduced 52.38%	1,000 $1,000
Q2 2022 Aug 04, 2022	BUY	$8.22 - $15.13 $7,398 - $13,617	900 Added 75.0%	2,100 $5,000
Q1 2022 Apr 14, 2022	BUY	$6.55 - $17.42 $7,860 - $20,904	1,200 New	1,200 $2,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.